Interleukin-2—Induced renal dysfunction in cancer patients is reversed by low-dose dopamine infusion

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1987 · 2.8K citations

Pharmacy, Immunology, Oncology +14

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

Steven A. Rosenberg, Michael T. Lotze, Linda Muul et al. · New England Journal of Medicine · 1985 · 2.6K citations

Medicine, Immunology, Oncology +15

Prognostic effect of weight loss prior tochemotherapy in cancer patients

William D. DeWys, Colin B. Begg, Philip T. Lavin et al. · The American Journal of Medicine · 1980 · 2.4K citations

Medicine, Nutrition, Oncology +14

Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

William H. West, Kurt W. Tauer, John R. Yannelli et al. · New England Journal of Medicine · 1987 · 1.2K citations

Medicine, Immunology, Oncology +16

Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

Steven A. Rosenberg, Michael T. Lotze, James Chih‐Hsin Yang et al. · Annals of Surgery · 1989 · 1K citations

Medicine, Immunology, Oncology +17